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The peptide transporter (PTR) family represents a group of
proton-coupled secondary transporters responsible for bulk
uptake of amino acids in the form of di- and tripeptides, an
essential process employed across species ranging frombacteria
to humans. To identify amino acids critical for peptide transport
in a prokaryotic PTR member, we have screened a library of
mutants of the Escherichia coli peptide transporter YdgR using
ahigh-throughput substrate uptake assay.Wehave identified 35
single pointmutations that result in a full or partial loss of trans-
port activity. Additional analysis, including homologymodeling
based on the crystal structure of the Shewanella oneidensis pep-
tide transporter PepTso, identifies Glu56 and Arg305 as potential
periplasmic gating residues. In addition to providing new
insights into transport by members of the PTR family, these
mutants provide valuable tools for further study of the mecha-
nism of peptide transport.
Amino acid uptake provides a critical source of nitrogen,
sulfur, and metabolic intermediates for many organisms.
Amino acids are often transported into the cell in the form
of short peptides to efficiently mediate their bulk uptake.
Although several different systemsmediating peptide transport
exist in bacteria and fungi, only the peptide transporters
(PTR),6 also called proton oligopeptide transporters, are con-
served in higher organisms, including humans (1, 2). Likemany
proton-coupled transporters, the PTR family is a subdivision of
the major facilitator superfamily (MFS) (3).
Sequence alignment among members of the PTR family
across species reveals three conserved motifs in the protein
sequence (4) (supplemental Fig. S1). The first such motif is
found in the first predicted transmembrane helix, whereas the
second is found in loop 2-3 and corresponds to the motif
GXXX(D/E)(R/K)[X]G[X](R/K)(R/K), where [X] is either one
or two amino acids, which is also found inmanyMFS transport-
ers (5, 6). The third motif, the PTR signature motif FXXFYXX-
INXGS, is located in the fifth predicted transmembrane helix of
PTRmembers, andmutation of these residues leads to reduced
transport activity or changes in substrate selectivity (7, 8). In
addition, chimeric studies on human PTRmembers PEPT1 and
PEPT2 have revealed that helices 2–5 as well as 7 contain resi-
dues that mediate substrate recognition (9). This is supported
by cysteine scanning mutagenesis of residues in helices 5 and 7
of PEPT1, which suggests that residues in these helices line the
substrate translocation pathway (8, 10).
PTR familymembers possess a large number of possible sub-
strates, including essentially all 400 possible di- or 8000 tripep-
tides. For human PEPT1 and PEPT2, the most well character-
ized PTRs, transport is stereoselective for the L-enantiomers of
amino acids, although D-amino acids are accepted in the N-ter-
minal position. Substrate affinity varies depending on the
sequence of the particular di- or tripeptide (11). Furthermore,
these transporters are able to take up peptidomimetics such as
-lactam antibiotics, some angiotensin-converting enzyme
inhibitors, and some antiviral pro-drugs, such as valaciclovir
(12). Due to the presence of PEPT1 in the brush-border mem-
brane of the small intestine, and PEPT2 in the kidney and
blood-brain barrier, these proteins significantly influence the
systemic availability of these and other pharmacological com-
pounds (12).
The Escherichia coli PTR protein YdgR, also called DtpA, is
one of the few prokaryotic PTR members to have been charac-
terized and shows substrate selectivity similar to that of PEPT1
(13, 14). Recently, the crystal structure of another prokaryotic
PTR family member from Shewanella oneidensis, referred to as
PepTso, was determined and revealed a fold very similar to that
of other MFS transporters, including LacY, GlpT, and EmrD
(15–18). The substrate binding cavity is lined with conserved
residues, many of which were previously identified as critical
for function (17). However, several functional residues, includ-
ing His61 and Glu316, which are suggested to be essential for
protonation and/or periplasmic gating, are not conserved
between PepTso and other bacterial PTRs, including YdgR.
To identify additional residues critical for the function of
YdgR and its homologues, we have performed random
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mutagenesis on this transporter and utilized a high-throughput
substrate uptake assay to identify mutants exhibiting loss-of-
function phenotypes. The results of this assay combined with
additional analysis allowed us to identify 15 mutations leading
to a complete loss-of-function phenotype, and 12 furthermuta-
tions showing partial loss-of-function. In addition, 6 mutations
were identified that exhibit this phenotype only in one of the
uptake assays. Mapping of these residues onto a homology
model of YdgR based on the PepTso structure and additional
comparison to the known structure of the lactose permease
LacY (15) allows for prediction of the potential functions of
several of these residues, including Glu56, Phe289, Met295, and
Arg305. Further analysis of Glu56 and Arg305 reveals that these
residues may function as periplasmic gating residues in YdgR
and other close bacterial homologues.
EXPERIMENTAL PROCEDURES
Molecular Cloning—The full-length ydgR genewas amplified
from E. coli genomic DNA and cloned into the pCS19 vector
(kind gift fromMichael Ehrmann (19)) using theNcoI and BglII
restriction sites. Site-directed mutagenesis was performed as
described in Ref. 20.
Random Mutagenesis—Random mutations were introduced
into regions of the ydgR gene encompassing helices 2–4 (H2–4;
base pairs 130–444) and helices 6–8 (H6–8; base pairs 535–
1000) using theGeneMorph II RandomMutagenesis Kit (Strat-
agene). To determine the mutation frequency in each library,
the resulting PCR products were inserted into the pJET cloning
vector using the GeneJET Cloning Kit (Fermentas). At least 10
different clones for each library were sequenced to estimate a
mutation frequency of 0.35% for library H2–4 and 0.65% for
library H6–8. The PCR products were then used as megaprim-
ers with pCS19-YdgR as a template, to create two libraries of
mutants in the pCS19 background.
Alafosfalin Growth Assay—The mutant libraries were trans-
formed into E. coli BL21(DE3) and individual colonies were
grown in 96-well plates under two conditions, one containing
200 l of Luria-Bertani (LB) medium plus the antibiotic ampi-
cillin, and one additionally containing 200 g/ml of the antibi-
otic alafosfalin (Sigma). A600 was monitored 1 and 5 h after
induction of ydgR expression. Clones exhibiting a growth
advantage when compared with native YdgR, as determined by
visual inspection of the growth curves, were sequenced within
the entire open reading frame to identify the mutation(s). Sev-
eral clones of each mutant identified in this manner were then
re-tested in the growth assay to eliminate false positives.
Isolation of E. coli Membrane Fractions—Cell pellets from
50-ml cultures of C43(DE3) cells transformed with mutant or
control constructs were harvested and membranes were iso-
lated as described in Ref. 21. Equal concentrations of mem-
branes from each construct were analyzed by SDS-PAGE and
Western blot using an -His-HRP-conjugated antibody (Qia-
gen). The intensity of each band was quantified using the
ImageJ software (22).
FIGURE 1.Selectionofmutantsbasedon theability to survive in thepres-
ence of alafosfalin. Cells expressing individual clones from each mutant
library were grown in the absence (A) and presence (B) of alafosfalin and
protein expression was induced at 2.5 h. A600 was measured at 1 h and 4.5 h
after induction. Representative primary data are shown for the native trans-
porter (WT), the Y156A mutant (Y156A), and the clones later identified as
mutants N306I and L324V. Reported A600 values are from measurements in
96-well plates, and are2.5 times lower than A600 determined using a 1-cm
path length. The means of triplicate measurements of A600 for the native
transporter and the Y156A loss-of-functionmutant in the presence of alafos-
falin from three individual experiments were compared using a paired t test
within the Graphpad Prism 5.0 software, and were found to have a p value
0.0024, indicating that the difference is statistically significant.
TABLE 1
Mutants isolated in the primary screen
Single mutants,
library H2–4
Single mutants,
library H6–8
Double mutants,
library H2–4
Double mutants,
library H6–8
E56G M154Ka L52P, K130E L221R, V316L
S59P L190V S64Y, A99E Q242H, F288L
I60N N196K S67T, A68P G255D, N306K
A68P F197I V70I, L80F I256F, I259F
G78C V252E Y71C, A75D E263D, E317G
G86R A264P W79R, I91N M275L, F279I
L98R K274I G86S, P133T E284G, A285V
I100V A285V G89R, K130T F289I, E317G
G101D F289L A95T, P133L V290A, Q320H
I122N F289S A99V, K130I Y292S, I331T
A123V M295K Y116C, M119K T297R, A315T
G127D T297A M117I, S134P L299P, R305H
L136R N300I L299R, L312M
L137H N300Y F302C, R305P
F301I P308R, A371V
A303G L312S, A405T
R305C Q322L, A323P
N306I
Q320L
L324V
P326Q
aMutation occurs outside of the mutagenized region.
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Uptake of -Ala-Lys(AMCA)—Uptake of -Ala-Lys-AMCA
(Biotrend) was measured essentially as described in Ref. 14,
however, a 2.5 mM -Ala-Lys-AMCA stock solution was used.
Uptakewasmeasured in 25mMTris buffer at pH 7.5 containing
140 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.8 mM MgSO4, and
5 mM glucose. Fluorescence measurements were additionally
normalized to A600. Competition assays were carried out in the
presence of 0 to 75 mM alafosfalin or alanyl-alanine (Bachem
AG). IC50 valueswere determined by nonlinear regression anal-
ysis using the software program GraphPad Prism 5.0.
Homology Modeling—The HHPred-generated alignment of
YdgR with PepTso (PDB code 2XUT) was used as the basis for
the alignment input into the program Modeller (9 version 8)
(23, 31). Evaluation of this model with PROCHECK resulted in
93.8% of the residues in the core region, 5.2% in the allowed
region, 0.5% in the generously allowed region, and 0.5% disal-
lowed (24). Figs. 5 and 6 were generated using the software
package MOE (Molecular Operating Environment, version
2009.10, Chemical Computing Group, Montreal, Canada). For
Fig. 6, the LacY (PDB code 2CFQ) and PepTso structures and
the YdgR homology model were aligned using the Superposi-
tion tool in MOE.
RESULTS
Isolation of YdgR Loss-of-function Mutants—To identify res-
idues critical for peptide transport in the E. coli YdgR protein,
we used PCR mutagenesis to generate mutant libraries in two
regions of the ydgR gene. The first library, encompassing helices
2–4 (H2–4), spans amino acids 44–148 of the ydgR gene (base
pairs 130–444), and the second library, encompassing helices
6–8 (H6–8), spans amino acids 179–334 (base pairs 535–
1000) (supplemental Fig. S1).
These two libraries were then tested for functionality based
on the ability to transport the phosphonopeptide antibiotic ala-
fosfalin, which is a specific substrate of prokaryotic PTRs, trans-
port of which leads to inhibition of cell growth (25). Growth in
TABLE 2
Membrane expression and transport characteristics of mutants isolated in the primary screen
Mutant
Growth
advantagea
Uptake of
-Ala-Lys(AMCA)b
Membrane
expressionc
Corrected
uptaked
Predicted
location
% % %
Empty vector 2.8 0.5 0 1 0 0
Wild-type 1.0 0.2 100 5 100 100
Y156A 2.5 0.5 2 1 96 2 Helix 5
No membrane localization
I100V 2.6 0.5 3 1 0 0 Helix 3
L137H 2.4 0.6 1 4 0 0 Helix 4
LOF mutants
E56G 2.3 0.1 10 4 89 11 Helix 2
S59P 2.5 0.3 -1 2 100 -1 Helix 2
I60N 3.3 0.5 1 2 106 1 Helix 2
A68P 2.6 0.3 1 1 105 1 Helix 2
G78C 2.3 0.4 1 3 91 1 Helix 2
L98R 2.4 0.4 1 1 114 1 Helix 3
L136R 2.5 0.5 0 1 79 0 Helix 4
A285V 2.3 0.2 11 6 105 10 Helix 7
F289L 2.4 0.2 1 1 81 1 Helix 7
F289S 2.1 0.3 -1 4 67 -1 Helix 7
M295K 2.2 0.2 -1 2 82 -1 Helix 7
T297A 2.4 0.1 3 1 103 3 Helix 7
N300I 2.7 0.5 7 1 116 6 Helix 7
F301I 2.7 0.2 2 1 75 2 Helix 7
Q320L 2.2 0.5 7 3 127 6 Helix 8
Partial LOFs
G86R 1.7 0.3 0 3 94 0 Loop 2–3
G101D 1.2 0.3 35 12 113 31 Helix 3
I122N 1.5 0.1 17 4 117 15 Helix 4
A123V 1.3 0.5 23 1 61 38 Helix 4
G127D 1.3 0.2 60 8 24 240 Helix 4
N196K 1.9 0.2 35 4 120 29 Helix 6
A264P 1.7 0.3 39 2 88 44 Helix HB
N300Y 3.3 0.4 25 8 62 40 Helix 7
A303G 1.3 0.2 42 9 94 45 Helix 7
R305C 1.7 0.1 3 1 62 5 Helix 7
N306I 1.4 0.2 21 1 100 21 Helix 7
P326Q 1.6 0.3 2 2 57 4 Helix 8
Selectivity mutants
M154K 2.4 0.2 257 70 93 276 Helix 5
L190V 2.6 0.5 105 25 89 118 Helix 6
F197I 2.7 0.4 142 26 86 165 Helix 6
V252E 2.2 0.2 87 7 84 104 Helix HB
K274I 2.5 0.3 59 21 55 107 Helix 7
L324V 1.8 0.5 242 11 80 303 Helix 8
a Data are represented as the fold difference in A600 of mutant versus native transporter in the presence and absence of alafosfalin 5 h post-induction: (Amutant  Alafos./
AWT  Alafos)/(Amutant  Alafos/AWT  Alafos). Error values represent S.D. of triplicate measurements from at least two different experiments.
b Fluorescence values are normalized after setting the value of the overexpressed native transporter to 100%.
c %Membrane expression was determined by quantitation of the band intensity on the Western blots shown in Fig. 2 using ImageJ software (22) and normalized by setting
the value of the overexpressed native transporter to 100%.
d Corrected uptake represents: (% uptake of -Ala-Lys(AMCA)/% Membrane expression) 100.
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the absence and presence of alafosfalin was monitored by mea-
suring A600 at several time points after induction of ydgR
expression (Fig. 1). Cells expressing transporters with muta-
tions leading to a loss-of-function (LOF) phenotype are
expected to grow normally in the presence of alafosfalin,
whereas cells expressing the native transporter or transporters
with mutations that do not affect transport ability will fail to
survive, due to the toxic effect of the antibiotic. The Y156A
mutant, which represents the homologous mutation of Tyr167
from PepT1 and results in a non-functional transporter (26),
was used as a positive control. Representative data for 2 LOF
mutants isolated in this assay, the native transporter and the
Y156A mutant indicates that the mutants show a clear growth
advantage as compared with the native transporter in the pres-
ence of alafosfalin (Fig. 1).
Approximately 1600 mutants were screened in this assay,
600 from library H2–4 and 1000 from H6–8. From library
H2–4, 101 LOF mutants were isolated. After sequencing the
YdgR open reading frame, these consisted of 21 single amino
acid mutations and 12 with double amino acid mutations. The
remaining mutants contained single base pair deletions or
insertions resulting in a frameshift, silent mutations, stop
codons, or point mutations resulting in 3 or more amino acid
changes. The mutant M154K lies outside of the mutagenized
region, and therefore must have arisen independently during
library generation. From library H6–8, 170 LOF mutants were
identified. Initial sequencing revealed the frequent occurrence
of mutants containing a long insertion rather than single point
mutations,most likely occurring during themegaprimer ampli-
fication step. Therefore clones were pre-screened by colony
PCR to eliminate clones containing the insertion. The remain-
ing 118mutants were sequenced within the YdgR open reading
frame to identify mutations, and consisted of 27 single point
mutants (22 unique) and 17 double point mutants.
The mutants resulting in single amino acid changes were
re-assayed to confirm their phenotype, resulting in the identi-
fication of 8 false positives. The remaining 35 single mutants
and the 29 isolated doublemutants are shown in Table 1. Com-
parison of A600 values of the native and mutant clones 4–5 h
post-induction was used to calculate a numerical growth
advantage for each of the 35 single mutants (Table 2).
Functional Analysis Reveals Four Different Phenotypes—The
35 single mutants were then further characterized. To deter-
mine whether their phenotype is simply due to loss of protein
expression or membrane insertion, membrane localization was
determined by isolation of the membrane fraction from small-
FIGURE 2. Membrane localization of all mutants. The localization of mutants to the plasma membrane was tested by preparation of E. coli membranes,
analysis by SDS-PAGEandWesternblot, andquantitationof theband intensity.Molecularmassmarkers (kDa) are indicated to the leftof eachWesternblot. The
quantitation of the expression level of eachmutant is recorded in Tables 2 or 4.WT, membranes from cells overexpressing native YdgR; vec, membranes from
cells expressing the empty vector.
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scale cultures and verification of the presence of protein in the
membrane fraction byWestern blot using an -His antibody to
detect the C-terminal His6 tag of the protein. This analysis
revealed that two mutants, I100V and L137H, show no expres-
sion in themembrane fraction, whereasG127D is present in the
membrane at very low levels, and K274I is expressed at only
55% as compared with native YdgR (Table 2, Fig. 2). All other
mutants show expression levels of 60% or more, and interpre-
tation of their transport phenotype is not affected by their
expression level.
To further analyze the transport activity of the individual
mutants, their ability to take up the fluorescent substrate
-Ala-Lys(AMCA), a known substrate of YdgR (14), was
assessed and compared with that of the native transporter (Fig.
3). By compiling the data from the alafosfalin growth assay and
the -Ala-Lys(AMCA) uptake assay, the 35 mutants can be
divided into four phenotypic categories (Table 2). The first cat-
egory includes the twomutants that fail to localize to themem-
brane. The second and largest category comprises 15 mutants
that show a 2-fold or greater growth advantage in the presence
of alafosfalin, and less than 10% uptake activity as compared
with the native transporter. Most of these mutants represent
amino acid substitutions that dramatically alter the properties
of the side chain, such as hydrophobic to charged or vice versa,
ormutations to glycine or proline, whichmay significantly alter
the protein structure. However, we have also identified more
conservative mutations that lead to the same phenotype,
including F289L, T297A, and F301I.
The third category represents 12 mutants with a slight
growth advantage in the presence of alafosfalin, and uptake
activity ranging from20 to 60% of the native transporter. The
mutants G86R, R305C, and P326Q show very little transport in
the -Ala-Lys(AMCA) uptake assay, however, do retain some
ability to take up alafosfalin, and have therefore been included
in this category. Similarly, N300Y seems unable to transport
alafosfalin, but still retains significant ability to transport
-Ala-Lys(AMCA), particularly when correcting for its
reduced expression level. Again, many of these mutations
represent substitution of one type of amino acid for another,
however, they show milder phenotypes than the complete
loss-of-function mutants. Most interesting, the G127D
mutant maintains significant transport activity despite its
low expression level (Table 2).
A fourth intriguing group of mutants, which we refer to as
selectivity mutants, are those that exhibit a loss-of-function
phenotype in the alafosfalin growth assay, yet show uptake of
-Ala-Lys(AMCA) equivalent to or, in some cases, even greater
than that of the native transporter (Table 2). Thiswould suggest
that these mutations do not affect the ability of the protein to
transport substrates, but rather may affect substrate selectivity
or affinity. Although the uptake assay is performed in minimal
media with only one potential substrate present, the alafosfalin
growth assay is performed in complex media (LB), which con-
tains other potential di- and tripeptide substrates. Although the
presence of competitors in complex media does not inhibit
transport of alafosfalin by the native transporter, higher affinity
FIGURE 3. Uptake of -Ala-Lys(AMCA) reveals distinct phenotypes. The ability of each mutant to take up the fluorescent dipeptide substrate -Ala-
Lys(AMCA)wasmeasured and comparedwith that of the native transporter.A, representative data for uptake by native YdgR, empty vector, and 6mutants are
shown under conditions including either buffer alone, -Ala-Lys(AMCA) alone, or -Ala-Lys(AMCA) plus 10 mM of a dipeptide competitor (Leu-Ala, leucyl-
alanine). Data are shown as raw fluorescence units (RFU) normalized to A600. Error bars represent standard deviations from triplicate measurements. B, after
subtraction of nonspecific transport, as measured by residual transport by cells expressing the empty vector, the transport ability of each mutant was
normalizedwith respect to thenative transporter,whichwas set to 100%. Error bars represent standarddeviations of triplicatemeasurements fromat least two
different experiments.Wild-type (WT), vector (vec), and Y156A controls are shown as black bars, mutants are grouped and shaded according to the phenotypic
categories shown in Table 2. A black line is used to indicate 100% transport.
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interaction with competitors, and/or lower affinity interaction
with alafosfalin, may prevent alafosfalin uptake in these
mutants.
Selectivity Mutants Show Lower Apparent Affinity for
Alafosfalin—To test the hypothesis that these mutants have
a lower apparent affinity for alafosfalin than the native trans-
porter, we determined the IC50 and Ki values for alafosfalin
for these six mutants by performing the -Ala-Lys(AMCA)
uptake assay in the presence of increasing concentrations of
alafosfalin (Fig. 4A, Table 3). This experiment reveals that
mutants M154K, L190V, F197I, V252E, and L324V have Ki
values 3.5–13.5-fold higher than the native transporter, indi-
cating weaker interaction with alafosfalin. In contrast, the
mutant K274I has a Ki value equal to that of the native
transporter.
The structure of alafosfalin mimics that of the dipeptide ala-
nyl-alanine, however, in alafosfalin (L-alanyl-L-1-aminoethyl-
phosphonic acid) the carboxyl group on the C-terminal moiety
is replaced by phosphonic acid. To determine whether these
mutants show lower apparent affinity for dipeptide substrates
with an unmodified carboxyl terminus, the IC50 and Ki values
for alanyl-alanine were also determined (Fig. 4B, Table 3). For
alanyl-alanine, theKi values for fivemutants are within2-fold
of that of the native transporter, and for one mutant, M154K,
the apparent affinity is higher than that of the native trans-
porter. This suggests that the lower apparent affinity for alafos-
falin for 5 of thesemutants is not a general property of substrate
binding, but rather may be specific for the substrate alafosfalin.
We conclude that the loss of apparent affinity for alafosfalin is
related to the presence of the additional C-terminal charged
hydroxyl, either through direct steric hindrance of binding or
unfavorable charge-charge interactions. As the K274I mutant
shows apparent affinities similar to those of the native trans-
porter for both alafosfalin and alanyl-alanine, it is not clear from
these experiments why this mutant shows a LOF phenotype in
the alafosfalin growth assay.
Localizing Mutations Based on Homology Modeling—To
attempt to correlate the phenotype of individual mutations
with their location in the transporter, we generated a homol-
ogy model of YdgR based on the structure of PepTso (17).
PepTso shares 26% identity and 45% similarity with YdgR
(supplemental Fig. S1). Almost all of the residues in the pep-
tide binding site of PepTso are conserved in YdgR, and also
localize to the substrate cavity in our model (supplemental
Fig. S1, Fig. 5, A and B).
The majority of LOF mutants isolated in our screen are
located in helices 2, 4, and 7 of our homology model, with the
majority in helix 7 (Table 2, supplemental Fig. S1). Signifi-
cantly fewer mutants were found in helices 3, 6, and 8. This
correlates well with data from otherMFS family members, as
based on the structures of LacY, GlpT, EmrD, and PepTso,
helices 2, 4, and 7 are located in the hydrophilic cavity rep-
resenting the substrate translocation pathway and contain
many critical functional residues (15, 16–18). Residues that
when mutated result in a partial LOF phenotype are located
primarily in helix 4 (Ile122, Ala123, Gly127) or close to the end
of helix 7 (Asn300, Ala303, Arg305, Asn306), and appear to be
more distant from the substrate binding site (17) (Fig. 5,
supplemental Fig. S1).
Most of the LOF or partial LOF mutations isolated in our
screen are located in the transmembrane helices, and, as men-
tioned previously, represent quite severemutations. Therefore,
many of these mutations most probably lead to dramatic
changes in helix packing (I60N, L98R, I122N, L136R) or intro-
duce kinks or bends in the helices (S59P, A68P, G78C, G86R,
G101D, G127D, A264P, P326Q). However, several mutations
are more conservative (A285V, F289L, F301I) yet also result in
complete loss of function. Phe289 is of particular interest as in
our model this residue is in a position equivalent to that of
FIGURE 4. Competitive binding data for native YdgR and the V252E
mutant. A, inhibition of -Ala-Lys(AMCA) uptake by alafosfalin. Representa-
tive data for the native transporter (black squares) and the V252E mutant
(white triangles) from one experiment are shown. B, inhibition of -Ala-
Lys(AMCA) uptake by alanyl-alanine (Ala-Ala). Representative data for the
native transporter (black squares) and the V252E mutant (white triangles) are
shown. Data for all mutants are summarized in Table 3.
TABLE 3
Apparent affinities of the selectivity mutants for alafosfalin and ala-
nyl-alanine (Ala-Ala)
Alafosfalin Ala-Ala
YdgR mutant IC50a Kib IC50a Kib
mM
Wild-type 0.11 0.07 0.07 0.08 0.33 0.16 0.21 0.2
M154K 0.39 0.12 0.25 0.16 0.12 0.01 0.08 0.01
L190V 0.59 0.03 0.38 0.04 0.32 0.06 0.20 0.08
F197I 0.71 0.02 0.45 0.03 0.48 0.01 0.31 0.01
V252E 0.44 0.21 0.28 0.27 0.33 0.05 0.21 0.06
K274I 0.08 0.04 0.05 0.05 0.31 0.07 0.20 0.09
L324V 1.5 0.07 0.96 0.09 0.56 0.10 0.36 0.13
a IC50 values represent averages from at least two experiments with error calcu-
lated as S.D.
bKi values were determined using the equation: Ki IC50/(1 substrate	/KD.
The KD value used was 0.44 0.05 mM, which is the apparent affinity of YdgR
for -Ala-Lys(AMCA) as determined in Ref. 14.
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Trp312 in PepTso, one of the few residues lining the substrate
cavity that is not strictly conserved in YdgR (Fig. 5, A and B,
supplemental Fig. S1).
Another residue of interest is Met295, as it is located in the
substrate binding cavity of our homology model, and the
mutant M295K shows a complete loss of transport function
FIGURE 5.Homologymodeling revealsputative functional residues.Ahomologymodel of YdgRwasgeneratedbasedon the structureof thePepTso transporter
(PDBcode2XUT).TheYdgRbackbone iscoloredgrayandshowninribbonrepresentationwithaminoacidsshowninstick representation.Thetransmembranehelices
are labeled in gray.A, viewperpendicular to themembrane. Conserved amino acids lining the substrate binding cavity are coloredgreen, CPK. Phe289 andMet295 are
shown inmagenta, CPK. B, view parallel to themembrane from the cytoplasmic side. Colored as in A. C, view perpendicular to themembrane. Residues resulting in
selectivity against alafosfalin are colored blue, CPK.D, viewparallel to themembrane from the periplasmic side, colored as in C.
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(Table 2, Fig. 5, A and B). To determine whether the side chain
of Met295 plays a role in substrate binding, we created mutant
M295A andmeasured its ability to transport substrates in both
the alafosfalin growth assay and the -Ala-Lys(AMCA) uptake
assay. M295A is unable to transport alafosfalin, with a growth
advantage of 2.3  0.1 over native YdgR (Table 4). However,
M295A shows 70% -Ala-Lys(AMCA) uptake activity as com-
pared with native YdgR, which increases to 89%when account-
ing for the reduced expression level of the mutant (Fig. 7A,
Table 4). Therefore we conclude that this residue does not play
a significant role in mediating substrate interaction in general,
but may modulate affinity toward certain substrates, as it is
selective against alafosfalin.
The residues that whenmutated show selectivity against ala-
fosfalin are, perhaps surprisingly, located distant from the sub-
strate binding cavity (Fig. 5, C and D). Residues Leu190 and
Phe197 are located in helix 6 andmost likely affect packing with
the adjacent helices 1, 3, and 4. Val252 is located in helix HB of
the membrane hairpin, which is not thought to play a role in
transport, but may also affect packing of adjacent helices.
Met154 is located at the cytoplasmic end of helix 5, whereas
Lys274 is located at the cytoplasmic end of helix 7. Leu324 is
located in helix 8, within the strictly conserved “LNP” motif,
and its mutation may affect the interface with helices 10 and 7
(Fig. 5, C and D, supplemental Fig. S1).
Several polar or charged residues that were isolated as LOF
mutants (Glu56, Ser59, Asn300, Arg305, Asn306) are located in the
periplasmic halves of helices 2 and 7, and may form part of a
hydrogen bonding network critical for closing of the periplas-
mic cavity, as seen in LacY and GlpT (27, 28). As the putative
gating residues of the peptide transporter PepTso, His61 and
Glu316, are not conserved in YdgR and many other bacterial
PTRs (17) (supplemental Fig. S1), we hypothesized that one or
more of these residues are potential candidates for the periplas-
mic gating residues of YdgR. To compare the positions of these
residues to the putative gating residues of PepTso and the pre-
viously characterized gating residues of LacY, we aligned the
structures of PepTso, LacY, and the YdgR homology model.
Glu56 and Arg305 are within close proximity in our homology
model, and are located in positions similar to the LacY gating
residues Ile40 and Asn245 (28) (Fig. 6).
Glu56 and Arg305 Are Potential Gating Residues—To deter-
mine whether any of the charged residues near the periplasmic
ends of helix 2 and 7 isolated in our screen may be responsible
for periplasmic gating we first mutated Glu56, Ser59, Asn300,
Arg305, and Asn306 to alanine. If the side chains of any of these
residues are involved in periplasmic gating, we would expect
mutation to alanine to result in a LOF phenotype similar to that
of the original mutation.
We tested these new mutants in the alafosfalin growth assay
and -Ala-Lys(AMCA) uptake assay. This analysis reveals that
mutants N300A and R305A have phenotypes identical to those
of the original mutation isolated in the screen, suggesting a
functional role for the side chains of these amino acids (Fig. 7A,
Table 4). E56A also shows a loss-of-function phenotype, how-
ever, this is due to a dramatic loss in membrane expression
(Table 4, Fig. 2). However, because E56G also displays a LOF
phenotype and localizes to the membrane, we hypothesized
that theGlu56 side chain is also critical for function. In contrast,
as Ser59 and Asn306 show an increase in transport activity as
compared with the original mutation, we conclude that these
residues are unlikely to be critical gating residues. Additionally,
we mutated Ser64 to alanine, as this residue is in a position
equivalent to that of His61 in PepTso (supplemental Fig. S1) and
tested this mutant in the -Ala-Lys(AMCA) uptake assay,
where it displays activity equal to that of the native transporter,
making this side chain unlikely to play a role in gating (Fig. 7A,
Table 4).
To test whether E56 interacts with Asn300 or Arg305 we cre-
ated several “charge-swapped” transporters, in which Glu56 is
mutated to either asparagine or arginine, and Asn300 or Arg305
is mutated to glutamate. We also included Asn306 in this study
due to its proximity to Arg305. We expected that transporters
containing the single mutations would be inactive, whereas if
the side chains of these residues form a hydrogen bond or char-
ge-based interaction, a doublemutant in which the residues are
swapped may rescue activity. When tested, the single mutants
all show no activity in the -Ala-Lys(AMCA) uptake assay (Fig.
7B, Table 4). The double mutants tested are also inactive, with
the exception of the E56N/R305E double mutant, in which
transport activity is restored to 35% of the native transporter,
and the E56R/R305E doublemutant, inwhich transport activity
is dramatically increased to 220% of the native transporter (Fig.
7B, Table 4). We therefore propose that Glu56 and Arg305 are
the periplasmic gating residues in YdgR, fulfilling the roles of
His61 and Glu316 in PepTso.
DISCUSSION
We have identified residues in the E. coli YdgR peptide
transporter that compromise transport ability when
TABLE 4
Membrane expression and transport characteristics of alanine and
charge-swapmutants
Mutant
Growth
advantagea
Uptake of
-Ala-Lys(AMCA)b
Membrane
expressionc
Corrected
uptaked
% % %
E56A 2.6 0.5 9 1 7 129
E56N 15 5 106 14
E56R 4 3 95 4
S59A 0.8 0.2 149 36 111 134
S64A 95 19 72 132
M295A 2.3 0.1 72 8 81 89
N300A 2.6 0.1 24 13 88 27
N300E 9 4 85 11
R305A 2.4 0.6 7 3 85 8
R305E 9 4 79 11
N306A 1.2 0.1 72 8 87 8
N306E 8 3 87 9
E56N, N300E 2 2 77 3
E56R, N300E 2 1 92 2
E56N, R305E 35 15 81 43
E56R, R305E 220 66 101 218
E56N, N306E 2 2 93 2
E56R, N306E 2 2 96 2
a Data are represented as the fold-difference in A600 of mutant versus native trans-
porter in the presence and absence of alafosfalin 5 h post-induction: (Amutant 
Alafos/AWT  Alafos.)/(Amutant–Alafos/AWT  Alafos). Error values represent S.D. of
triplicate measurements from at least two different experiments.
b Fluorescence values are normalized after setting the value of the overexpressed
native transporter to 100%.
c %Membrane expression was determined by quantitation of the band intensity
on the Western blots shown in Fig. 2 using ImageJ software (22) and normalized
by setting the value of the overexpressed native transporter to 100%.
d Corrected uptake represents: (% uptake of -Ala-Lys(AMCA)/% membrane ex-
pression) 100.
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mutated, based on random mutagenesis and selection for
mutants with a loss-of-function phenotype. By generating a
homology model of YdgR based on the structure of PepTso,
we have localized these mutations to specific transmem-
brane helices with proximity to the substrate translocation
pathway. Based on our homology model, our functional data,
and studies of PepTso, LacY, GlpT, and PepT1 several inter-
esting insights emerge regarding individual residues as well
as YdgR function in general.
The phenotypes of several mutants correlate well with the
results of mutagenesis of other PTR or MFS members. Two of
the mutants isolated in our study, Gly78 and Gly86, confirm the
importance of the conserved MFS motif in loop 2–3, and are
both conserved in prokaryotic homologues of YdgR (supple-
mental Fig. S1). Gly78 is equivalent to Gly64 in LacY, which
seems critical for maintaining conformational flexibility, as
only mutation to alanine is tolerated at this position (29). In
agreement with studies on LacY, mutation of Gly78 shows a
more severe phenotype than mutation of Gly86 (6).
Wewere also able to identify Phe289 as the likely equivalent of
Trp312 of PepTso, one of the few residues in the substrate bind-
ing pocket that is not strictly conserved between YdgR and
PepTso. Both phenotypes of the Phe289 mutants, two of which
were isolated in our screen, and our homologymodel point to a
role for Phe289 equivalent to that of Trp312. In PepTso, Trp312 is
forming hydrophobic interactionswithTrp446 (Trp423 inYdgR)
in the substrate binding cavity. In human PEPT1, mutation of
the Trp312 equivalent Trp294 to alanine also results in reduced
transport activity (26), providing additional support for the role
of this residue in substrate transport.
We also propose Met295 as an additional residue in the sub-
strate binding pocket that may mediate substrate affinity. This
residue is conserved in many bacterial species, although not in
PepTso. As mutation of Met295 to alanine creates a selectivity
mutant, it is clear that even changes to less conserved residues
in the substrate binding pocket or in residues influencing pack-
ing of the helices lining the substrate cavitymay affect substrate
affinity and selectivity.
Because even conservative mutations distant from the sub-
strate translocation pathway, such as L190V or L324V, lead to
changes in the apparent affinity for selected substrates, we pro-
pose that YdgR undergoes large and dynamic conformational
transitions, as has been shown for LacY and GlpT (27, 30). Due
to the large number of mutations we isolated in helix 7, it
seems that in particular the interhelical interface of this helix
is critical for proper protein function. This is in agreement
FIGURE 6.Alignment of the YdgRmodel with LacY and PepTso identifies potential periplasmic gating residues. The YdgR homologymodel was aligned
with the crystal structures of LacY (PDB code 2CFQ) and PepTso (PDB code 2XUT) to compare the positions of the periplasmic gating residues from LacY (Ile
40,
Asn245) and PepTso (His
61, Glu316) with Glu56 and Arg305. A, view perpendicular to themembrane. The backbone of the YdgR homologymodel (cyan) is aligned
with that of the LacY structure (light gray) and that of PepTso (dark cyan). For clarity only helices lining the substrate cavity are shown, and are labeled in gray.
B, the isolated helices 2 and 7 of the aligned structures, colored as in A. Gating residues from each protein are shown in stick conformation.
Mutagenesis of YdgR Identifies Gating Residues
JULY 1, 2011•VOLUME 286•NUMBER 26 JOURNAL OF BIOLOGICAL CHEMISTRY 23129
 at U
niv of Queensland (CAUL) on October 26, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
with structural work on PepTso. Comparison between LacY
in the open-in conformation and PepTso in the occluded
conformation shows the greatest displacement in helix 7
(17). This underscores the similarity between YdgR andMFS
transporters.
Although the crystal structure of PepTso identified the
potential periplasmic gating residues His61 and Glu316, these
residues are not conserved inmost other prokaryotic PTR fam-
ily members. Through our mutagenesis screen, we identified
several candidate amino acids that may play a role in periplas-
mic gating, and we were able to confirm that two of these resi-
dues, Glu56 and Arg305, are critical for transport function, most
likely through formation of a charge-based interaction thatmay
regulate gating.As these residues are located on the periplasmic
termini of helices 2 and 7 in our homology model, they would
also be positioned close to the small extracellular cavity seen in
the PepTso structure, formed by the periplasmic halves of heli-
ces 2, 7, 11, and 12 (17). As this cavity has been proposed as the
entry site for peptide substrates (17), these residues are likely to
be properly positioned for coupling of gating and substrate
binding.
Comparison of the locations of the putative periplasmic
gating residues of PepTso and YdgR with those of LacY indi-
cates that the position of the periplasmic gate of YdgR seems
to be much closer to that of LacY than that of PepTso (Fig.
7B). The putative gating residues of YdgR show higher con-
servation within bacterial PTR family members than His61
and Glu316 of PepTso, however, they are also not conserved in
more distant homologues (supplemental Fig. S1). This sug-
gests that periplasmic gating may not be strictly conserved
within the PTR family, andmore than one periplasmic gating
mechanism may have evolved. Taken together, the results of
our analysis suggest that YdgR shares many functional sim-
ilarities with both PepTso and LacY, thus adding support to
the hypothesis that members of the MFS superfamily, and
perhaps other proton-coupled transporter families, share a
common fold and mechanism, despite transporting a wide
range of substrates.
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